Pharmaron, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile by GlobalData

VIEWS: 0 PAGES: 16

More Info
									       Pharmaron, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
       Reference Code: GDPH217051D                                                                                                           Publication Date: JAN 2013

      Company Overview                                                                                            Key Facts
      Pharmaron, Inc. (Pharmaron) is a pharmaceutical and biotechnology drug contract
                                                                                                                  Pharmaron, Inc., Pharmaceuticals & Healthcare,
      research organization, based in the US. It provides research and development
                                                                                                                  Key Facts
      service for like chemistry, biology, DMPK, pharmacology and chemical development
      industry. The service offered by the company includes chemistry, pharmaceutical                              Web Address                  www.pharmaron.com
      development and manufacturing, biology, in vitro ADME services, in vivo
                                                                                                                   Revenue (US$ million)                     NA
      pharmacology, GLP bioanalytical services, preclinical services and integrated R&D
      services. Pharmaron’s in vivo pharmacology services include oncology, metabolic                              Number of Employees                       NA
      diseases, CNS, pain, inflammation and other established animal models and                                    GlobalData
      procedures.

      Financial Deals Landscape
        Pharmaron, Inc., Pharmaceuticals & Healthcare, Deals by Type,                      Pharmaron, Inc., Pharmaceuticals & Healthcare, Deals By
        2007 to YTD 2013                                                                   Year, 2007 to YTD 2013


                                                                                                                     1                   1      1      1
                                                                                                              1




                                                                                               No. of Deals

                                                                                                                           0      0                           0
                                                                                                              0
                                                                                                                   2007   2008   2009   2010   2011   2012   YTD
                                                                                                                                                             2013


                                                                                           Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                           from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Pharmaron, Inc., Pharmaceuticals & Healthcare, Deals By
         Region, 2007 to YTD 2013


                               2
          No. of Deals




                         2

                                        1         1
                         1

                                                           0         0
                         0
                             North    Asia-     Europe   Middle   South
                             Americ   Pacific             East     and
                               a                          and     Central
                                                         Africa   Americ
                                                                    a



         Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData


        Pharmaron, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013
        Year                                                                    No. of Deals                                       Deal Value (US$ million)
        2007                                                                                                         1                                               NA
        2008                                                                                                        NA                                                NA
        2009                                                                                                        NA                                                NA
        2010                                                                                                         1                                                NA
        2011                                                                                                         1                                              40.00
        2012                                                                                                         1                                                NA
        YTD 2013                                                                                                    NA                                                NA
        Note: Deals include all announced pharmaceuticals & healthcare deals from 2006 onwards, deal values included wherever disclosed, GlobalData




Pharmaron, Inc. - Pharmaceuticals & Healthcare - Deals and                                                                                     Reference Code: GDPH217051D
Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                  Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Pharmaron, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ........................................................................ 3
       Pharmaron, Inc., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013......................................................................... 5
       Pharmaron, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 .................................................................... 6
       Pharmaron, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ..................................................................... 7
       Pharmaron, Inc., Pharmaceuticals & Healthcare, Deal Details........................................................................................................... 8
          Venture Financing........................................................................................................................................................................... 8
             Pharmaron Secures $40 Million In Series C Financing Round.................................................................................................... 8
             Pharmaron Secures Series A Financing ................................................................................................................................... 10
          Partnerships.................................................................................................................................................................................. 11
             Pharmaron Enters Into Drug Discovery Agreement With AstraZeneca ..................................................................................... 11
          Acquisition .................................................................................................................................................................................... 12
             Pharmaron Acquires Bridge Labs China From Bridge Labs ...................................................................................................... 12
       Pharmaron, Inc. - Key Competitors .................................................................................................................................................. 13
       Key Employees ................................................................................................................................................................................ 14
       Locations And Subsidiaries .............................................................................................................................................................. 15
          Head Office ................................................................................................................................................................................... 15
          Other Locations & Subsidiaries ..................................................................................................................................................... 15
       Appendix .......................................................................................................................................................................................... 16
          Methodology ..............................................................................
								
To top